| Trial ID: | L6028 |
| Source ID: | NCT00502138
|
| Associated Drug: |
Continuous Pramlintide Infusion
|
| Title: |
A Pilot Study of Continuous Subcutaneous Pramlintide Infusion Therapy in Patients With Type 1 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
IDDM
|
| Interventions: |
DRUG: Continuous Pramlintide infusion
|
| Outcome Measures: |
Primary: Fasting and postprandial pramlintide pharmacokinetics, Four months | Secondary: Hemoglobin A1c, body weight, blood glucose variability, patient satisfaction, four months|Hemoglobin A1c, 16 weeks
|
| Sponsor/Collaborators: |
Sponsor: University Diabetes & Endocrine Consultants | Collaborators: Amylin Pharmaceuticals, LLC.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
12
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2007-07
|
| Completion Date: |
2008-01
|
| Results First Posted: |
|
| Last Update Posted: |
2013-01-16
|
| Locations: |
University Diabetes & Endocrine Consultants, Chattanooga, Tennessee, 37403, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00502138
|
